The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

The Walk to Defeat ALS funds research, treatment, and a cure for Lou Gehrig’s Disease, otherwise known as ALS. The funds will ...

New research supports brain cell transplantation as a treatment for some neurological disorders. A team from McGill ...

Now, researchers from University of California San Diego and their colleagues report that they have identified a key pathway ...

In September 2024, Athira announced topline results from the LIFT-AD Phase 2/3 clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease. The study did not meet its primary or key ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

NeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe ...

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

An event aimed at finding a cure for Lou Gehrig’s disease, also known as ALS, is set to happen in South Alabama this weekend.

The ALS Association was in town on the morning of Nov. 2 for their fourth and final Walk to Defeat ALS event at Mount ...

Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...